Recent Updates
Recently added Catalysts
ARGX

argenx raises $750 million in gross proceeds in a global offering

Key Takeaway: argenx raises $750 million in gross proceeds in a global offering

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis

Full Press Release Details

argenx raises $750 million in gross proceeds in a global offering.
Last updated: May 27, 2020